Key Takeaways: Women are twice as likely as men to develop anxiety and depression, and declining testosterone is a significant contributor that most doctors overlook. Testosterone regulates serotonin, GABA, and amygdala function — the core circuitry behind mood and anxiety. Clinical studies show testosterone therapy reduces depression scores by up to 44.6% in peri- and postmenopausal women. If you have unexplained anxiety or depression that started in your late 30s or 40s, low testosterone belongs on the shortlist.
The Missing Diagnosis
Women are more than twice as likely as men to develop anxiety and depression. The conventional explanation points to estrogen, progesterone, and life stressors. But there is a third hormone that gets systematically ignored: testosterone.
By age 40, most women have lost roughly 50% of the testosterone they had at 20. By menopause, levels can plummet another 50%. During that same window — late 30s through the menopausal transition — anxiety and depression rates spike. The timing is not a coincidence.
The problem is that almost nobody connects these dots. A woman walks into her doctor's office with new-onset anxiety, insomnia, or a flat mood she cannot shake. She leaves with an SSRI prescription. Her testosterone level never gets checked. A 2021 meta-analysis confirmed that depressed women show significantly different testosterone levels compared to healthy controls — yet hormone testing remains absent from standard depression workups.
This is one of the most consequential blind spots in women's healthcare. If mood symptoms are driven by hormone deficiency, no amount of cognitive behavioral therapy or serotonin modulation will fix the root cause.
How Testosterone Regulates Mood and Anxiety
Testosterone is not just a sex hormone. It is a neuroactive steroid that directly shapes how your brain processes emotions, threat, and stress.
The Serotonin Connection
Serotonin is the neurotransmitter most associated with mood stability, and it is the primary target of SSRIs. Testosterone directly influences the serotonin system. A PET imaging study of surgically postmenopausal women at Karolinska Institute showed that estrogen and testosterone treatment altered serotonin transporter binding in the brain. The serotonin transporter (5-HTT) controls how much serotonin stays active in the synapse. When testosterone drops, serotonin regulation becomes less efficient — producing the same symptoms that SSRIs are designed to treat.
This has a critical clinical implication: if low testosterone is impairing your serotonin system, replacing testosterone addresses the upstream cause. An SSRI only patches the downstream symptom.
The Amygdala and Fear Processing
The amygdala is the brain's threat detection center. It is dense with androgen receptors, and testosterone directly modulates its activity. Research shows that testosterone administration in middle-aged women restored amygdala reactivity to levels comparable to younger women. The amygdala also connects to the prefrontal cortex through circuits that regulate emotional control — when testosterone drops, the prefrontal cortex loses some of its ability to dampen the amygdala's fear signals.
This is the biology behind that feeling of free-floating anxiety that has no identifiable trigger. The threat detection system is firing without proper regulation.
The HPA Axis and Stress Response
Testosterone modulates the hypothalamic-pituitary-adrenal (HPA) axis — the body's central stress response system. Adequate testosterone levels help keep cortisol responses proportionate to actual threats. When testosterone declines, the HPA axis becomes more reactive, producing exaggerated stress responses to minor triggers.
Women with low testosterone often describe a shift from handling stress well to feeling overwhelmed by things that never bothered them before. That is the HPA axis losing its hormonal brake.
The Clinical Evidence
The research on testosterone and mood in women has accelerated significantly in recent years. Here is what the data actually shows.
The 510-Woman Mood Study
A 2024 pilot study from a UK specialist menopause clinic tracked 510 peri- and postmenopausal women who received testosterone cream or gel for persistent mood and cognitive symptoms. Using the modified Greene Climacteric Scale, researchers measured nine specific mood and cognitive symptoms at baseline and at 4 months.
The results: all nine symptoms improved significantly. This included anxiety, depressed mood, irritability, difficulty concentrating, and mental fatigue. The improvements were consistent across both perimenopausal and postmenopausal groups.
The 920-Woman Cohort
A larger 2025 retrospective cohort from the UK's largest specialist menopause clinic studied 920 women receiving hormone therapy including transdermal estradiol and testosterone. Depression and anxiety symptoms were measured using the Meno-D questionnaire.
Mean depression scores dropped by 44.6% after an average of 107 days of treatment. Mood improvement was significant across every individual symptom measured, and the effect held for both perimenopausal and postmenopausal women.
A 44.6% reduction in depression scores in under four months — with a hormone that has fewer side effects than most antidepressants — is a finding that deserves far more attention than it gets.
The Premenopausal Evidence
This is not limited to menopause. A randomized, placebo-controlled crossover trial studied premenopausal women (mean age 39.7) with low libido and testosterone levels. After 12 weeks of transdermal testosterone cream (10 mg/day), participants showed significant improvements in well-being, mood, and sexual function compared to placebo.
This matters because it demonstrates testosterone's mood effects are not dependent on the menopausal context. If your testosterone is low, your mood circuitry is affected regardless of your reproductive stage.
What the Meta-Analyses Say
A 2021 meta-analysis and Mendelian randomization study found a significant association between testosterone levels and depression in women, particularly in the premenopausal group. The Mendelian randomization component (which tests causal direction) was inconclusive — meaning the low testosterone could be either a cause or a consequence of depression. In clinical practice, this distinction matters less than you might think: regardless of which came first, restoring testosterone levels to the physiological range improves mood symptoms in the studies that have tested it.
Recognizing Hormone-Driven Anxiety vs. Other Causes
Not all anxiety is hormonal. But hormone-driven anxiety has a recognizable pattern that distinguishes it from situational anxiety, generalized anxiety disorder, or trauma-related anxiety.
Signs Your Anxiety May Be Hormone-Related
- Age of onset: New or worsening anxiety that started in your late 30s or 40s without a clear life trigger
- Cyclical patterns: Symptoms that fluctuate with your menstrual cycle (worse in the luteal phase) or worsened dramatically around perimenopause
- Physical symptoms dominant: More physical manifestations (heart racing, chest tightness, restlessness) than cognitive worry
- Concurrent low-T symptoms: Fatigue, low libido, brain fog, and muscle loss alongside the anxiety — see the full list of low testosterone symptoms in women
- Poor SSRI response: Antidepressants helped partially or not at all
- Morning pattern: Anxiety worse upon waking, when cortisol peaks and testosterone is at its daily low
The Hormone Panel You Need
Standard depression and anxiety workups do not include testosterone. You need to specifically request:
| Test |
Why It Matters |
| Total testosterone |
Overall production level; look for below 20 ng/dL as a flag |
| Free testosterone |
The bioactive fraction; below 1.5 pg/mL is clinically significant |
| SHBG |
High SHBG binds testosterone, lowering the free fraction |
| Estradiol |
Context for the full hormonal picture |
| DHEA-S |
Precursor to testosterone; low levels suggest adrenal contribution |
| Cortisol (AM) |
Rules out HPA axis dysfunction as the primary driver |
| Thyroid panel (TSH, fT3, fT4) |
Thyroid dysfunction mimics many of the same symptoms |
Testing should be done in the morning, ideally days 3-9 of your cycle if you are still menstruating. For the most comprehensive approach, see our guide on testosterone and women's health.
Treatment: What Actually Works
If blood work confirms low testosterone alongside mood symptoms, the treatment approach is straightforward — but it requires a provider who understands female hormone therapy.
Testosterone Replacement
The 2019 Global Consensus Position Statement endorsed testosterone therapy for postmenopausal women, and the clinical evidence for mood benefits continues to build. Standard protocols for women:
- Testosterone cream: 5-10 mg/day applied to the inner thigh or labia. This is the most commonly prescribed form for women and allows precise dose titration.
- Testosterone gel: Similar dosing, some women prefer the application method. See our testosterone gel guide for women.
- Testosterone pellets: Subcutaneous implants lasting 3-4 months. Less flexibility for dose adjustment but convenient. Details in our testosterone cream guide.
The target is physiological replacement — restoring levels to the range of a healthy premenopausal woman (total testosterone 50-70 ng/dL, free testosterone 3-5 pg/mL). This is roughly 1/10th to 1/20th of male doses. At these levels, the safety profile is strong and virilization risk is minimal.
Timeline for Mood Improvement
Based on the clinical data:
| Timeframe |
Expected Changes |
| 2-4 weeks |
Improved energy, reduced morning anxiety, better stress tolerance |
| 4-8 weeks |
Measurable improvements in depression scores, reduced irritability |
| 8-12 weeks |
Significant mood stabilization, improved cognitive clarity |
| 3-4 months |
Full effect on anxiety and depression symptoms (consistent with the 107-day average in the 920-woman study) |
If you do not notice any mood improvement by 8 weeks, your provider should recheck levels and consider dose adjustment.
Combining with Estradiol
For perimenopausal and postmenopausal women, testosterone alone may not be sufficient. Estradiol also plays a major role in serotonin regulation. The largest cohort study showing the 44.6% depression reduction used both transdermal estradiol and testosterone. Many women need both hormones optimized.
This is where working with a clinic that specializes in women's hormone therapy makes a difference. A provider experienced in hormone therapy for menopause can build a protocol that addresses all the hormonal contributors to mood symptoms — not just one.
For women looking for a provider with specific expertise in female HRT, Peter MD offers women's hormone therapy with testosterone prescribing, and our best online HRT clinics for women comparison covers the full landscape.
What About SSRIs?
SSRIs are not the wrong answer for every woman with anxiety or depression. But they are the wrong first answer when hormone deficiency is driving the symptoms. Here is a practical framework:
- Hormone deficiency confirmed: Start testosterone (and estradiol if indicated). Give it 8-12 weeks before adding anything else.
- Normal hormones, clear mood disorder: SSRIs or other psychiatric medications are appropriate first-line treatment.
- Low hormones + severe symptoms: It is reasonable to start both simultaneously, then consider tapering the SSRI once hormones are optimized and stable.
- Already on an SSRI with partial response: Get hormones tested. Adding testosterone to an SSRI is safer than stacking additional psychiatric medications.
The critical point: you cannot make this decision without blood work. Any provider prescribing antidepressants for a woman in her late 30s to 50s without checking testosterone is practicing with incomplete information. Our HRT cost guide breaks down what testing and treatment costs with and without insurance.
The Perimenopause Anxiety Spike
Perimenopause deserves special attention because it is when hormone-driven anxiety hits hardest and gets misdiagnosed most often.
During perimenopause, hormone levels do not decline smoothly. They fluctuate wildly — estradiol can swing from menopausal lows to premenopausal highs within the same month. Testosterone, meanwhile, continues its steady decline. The combination of erratic estrogen and falling testosterone creates a neurochemical environment primed for anxiety.
Women in perimenopause frequently describe their anxiety as qualitatively different from anything they experienced before. It feels physical rather than cognitive. Panic-like symptoms appear without psychological triggers. Sleep disruption amplifies everything.
The tragedy is how often this gets attributed to "stress" or "aging." A 45-year-old woman with new-onset panic attacks, disrupted sleep, and a vague sense of dread is not having a midlife crisis. She has a measurable hormone deficiency that responds to treatment. For a deeper look at the perimenopausal picture, see our guide on testosterone and perimenopause.
When to Seek Help
Get your hormones tested if you recognize three or more of these:
- New anxiety or depression that started after age 35 without an obvious cause
- Mood symptoms that are worse premenstrually or have escalated with cycle changes
- Fatigue that does not resolve with sleep, exercise, or stress management
- Loss of motivation or drive that feels biological, not situational
- Decreased libido alongside mood changes
- Brain fog, poor concentration, or word-finding difficulty
- Antidepressant treatment that has been partially or fully ineffective
- Family history of early menopause or surgical menopause
The combination of mood symptoms plus physical low-T symptoms is the strongest signal. If you are dealing with anxiety plus fatigue plus low libido plus brain fog, the probability that testosterone is involved is high.
Do not wait for your doctor to suggest hormone testing. Request it specifically. Ask for total testosterone, free testosterone, and SHBG at minimum. If your provider is unfamiliar with testosterone therapy for women, consider a specialist clinic — the field is evolving fast, and generalists are often years behind the evidence.
Frequently Asked Questions
References
-
McHenry J, et al. "Sex differences in anxiety and depression: role of testosterone." Front Neuroendocrinol. 2014. PubMed
-
Wang R, et al. "Testosterone in Female Depression: A Meta-Analysis and Mendelian Randomization Study." Biomolecules. 2021. PubMed
-
Jovanovic H, et al. "Effects of estrogen and testosterone treatment on serotonin transporter binding in the brain of surgically postmenopausal women — a PET study." NeuroImage. 2015. PubMed
-
van Wingen GA, et al. "Testosterone increases amygdala reactivity in middle-aged women to a young adulthood level." Neuropsychopharmacology. 2008. PubMed
-
Huxter JR, et al. "Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study." Arch Womens Ment Health. 2025. PubMed
-
Sheridan L, et al. "Transdermal oestradiol and testosterone therapy for menopausal depression and mood symptoms: retrospective cohort study." BMJ Mental Health. 2025. PubMed
-
Goldstat R, et al. "Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women." J Clin Endocrinol Metab. 2003. PubMed
-
Davis SR, et al. "Global Consensus Position Statement on the Use of Testosterone Therapy for Women." J Clin Endocrinol Metab. 2019. PubMed